Tag Archives: International

Opening Up Innovation

Cancer

Open Innovation has become a major theme in the life sciences over the last couple of years. Most of the attention has focused on initiatives where big pharma offers access to non-core assets to outside researchers in the hope that they will develop them successfully or form collaborations. In Sweden, AstraZeneca have followed this path, but interest in the concept has spread further down the discovery chain, generating creative initiatives from universities, tech transfer organizations, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Cranial Connections: Ontario’s Brain Research is Hardwired for Success

Moridi

Ontario has long been a leader in life sciences research and technology with brain exploration now taking centre-stage. Most recently, the provincial government committed $100 million to the Ontario Brain Institute, (OBI).  An independent nonprofit formed in 2010, the OBI  will help researchers and business leaders develop new treatments for neurological conditions ranging from Alzheimer’s and Parkinson’s to intractable epilepsy, cerebral palsy, autism and attention deficit and hyperactivity disorder. Headquartered in Toronto – a region that Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

The UK at BIO

The UK at BIO

There are more than 400 delegates from the UK attending the 2013 BIO International Convention. These include delegates from four innovative life science companies – Abcodia, Critical Pharmaceuticals, Nanomerics, and PsiOxus Therapeutics – who won the recent UK Trade and Investment (UKTI) Innovation Competition and will showcase their technologies to an international audience in Chicago. The UK presence at the convention will be centred on the UK pavilion (stand 4441) hosted by the BioIndustry Association (BIA) Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Convention Veterans Putting the “Super” in Super Sessions

Worldview

Featured in the BIO Buzz Center at last year’s Convention, two of our Super Session participants will once again join us to host a dynamic group of C-level industry thought leaders, sharing their perspectives on the current economic environment and major trends that will impact the future of the global industry. Ernst & Young will present insights from their annual report which looks to measure the industry performance through key metrics such as financial results, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Navigating the Rare Disease World

Susan Ruediger

The international orphan drug marketplace is expected to grow some 30 percent by 2014, fueled by the entrance of big pharmaceutical companies and U.S. legislation favoring development and coverage. This growth promises to improve the health of patients with debilitating and life-threatening disorders. Hoping to further the rare disease dialogue and relationship building opportunities, the 2013 Orphan Disease Forum will provide unique perspective on the orphan drug marketplace, regulatory considerations and much more. Operating within Read More >

Events  |  2 Comments  |  Email This Post
Tags: , , , , , , , ,